Vanderbilt spinoff company adds to local high-tech growth
Neurotargeting, LLC, a spinoff company founded by ViSE members Benoit Dawant, Pierre-Francois D’Haese, and Peter Konrad has been awarded a three-year $2.7 million grant to continue development of an integrated solution for the treatment and management of patients undergoing deep brain stimulation (DBS) procedures for the treatment of Parkinson’s disease and other neurological disorders.
For more than 10 years with NIH funding, this Vanderbilt interdisciplinary group has developed a system that facilitates the pre-operative, intra-operative, and post-operative phases of DBS procedures. The system which consists of a data repository called CranialVault and of a suite of software tools called CranialVault Explorer (CRAVE), is the first system designed to provide assistance for all phases of the procedure, from preoperative planning to surgical implantation and device programming.
For more information please see: http://engineering.vanderbilt.edu/news/2012/vanderbilt-spinoff-company-adds-to-local-high-tech-growth/